1. Home
  2. CMRE vs IOVA Comparison

CMRE vs IOVA Comparison

Compare CMRE & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

N/A

Current Price

$15.37

Market Cap

1.9B

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$8.28

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMRE
IOVA
Founded
1974
2007
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
CMRE
IOVA
Price
$15.37
$8.28
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$12.00
$9.00
AVG Volume (30 Days)
324.0K
18.5M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$47.74
Revenue Next Year
N/A
$40.31
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.84
$1.76
52 Week High
$18.06
$9.36

Technical Indicators

Market Signals
Indicator
CMRE
IOVA
Relative Strength Index (RSI) 54.31 64.57
Support Level $15.16 $3.57
Resistance Level $15.86 $9.36
Average True Range (ATR) 0.44 0.60
MACD 0.06 -0.02
Stochastic Oscillator 73.33 59.17

Price Performance

Historical Comparison
CMRE
IOVA

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: